Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1995 Apr 1;181(4):1551–1556. doi: 10.1084/jem.181.4.1551

Protection against HIV-1 gp120-induced brain damage by neuronal expression of human amyloid precursor protein

PMCID: PMC2191956  PMID: 7699335

Abstract

Expression of the HIV-1 envelope protein gp120 in brains of transgenic (tg) mice induces extensive neurodegeneration (Toggas, S. M., E. Masliah, E. M. Rockenstein, G. F. Rall, C. R. Abraham, and L. Mucke. 1994. Nature [Lond.]. 367:188-193.). To further analyze the pathogenesis of gp120-induced neurotoxicity and to assess the neuroprotective potential of human amyloid precursor proteins (hAPPs) in vivo, different hAPP isoforms were expressed in neurons of gp120/hAPP-bigenic mice: hAPP751, which contains a Kunitz-type protease inhibitor domain, or hAPP695, which lacks this domain. Bigenic mice overexpressing hAPP751 at moderate levels showed significantly less neuronal loss, synapto-dendritic degeneration, and gliosis than singly tg mice expressing gp120 alone. In contrast, higher levels of hAPP695 expression in bigenic mice failed to prevent gp120-induced brain damage. These data indicate that hAPP can exert important neuroprotective functions in vivo and that the efficiency of this protection may depend on the hAPP isoform expressed and/or on the level of neuronal hAPP expression. Hence, molecules that mimic beneficial APP activities may be useful in the prevention/treatment of HIV-1- associated nervous system damage and, perhaps, also of other types of neural injury.

Full Text

The Full Text of this article is available as a PDF (1.9 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraham C. R., Kanemaru K., Mucke L. Expression of cathepsin G-like and alpha 1-antichymotrypsin-like proteins in reactive astrocytes. Brain Res. 1993 Sep 10;621(2):222–232. doi: 10.1016/0006-8993(93)90110-9. [DOI] [PubMed] [Google Scholar]
  2. Akopyan T. Protein inhibitors of proteinases from brain. Neurochem Res. 1991 May;16(5):513–517. doi: 10.1007/BF00974868. [DOI] [PubMed] [Google Scholar]
  3. Alvarez J., Moreno R. D., Llanos O., Inestrosa N. C., Brandan E., Colby T., Esch F. S. Axonal sprouting induced in the sciatic nerve by the amyloid precursor protein (APP) and other antiproteases. Neurosci Lett. 1992 Sep 14;144(1-2):130–134. doi: 10.1016/0304-3940(92)90733-n. [DOI] [PubMed] [Google Scholar]
  4. Bagetta G., Finazzi-Agrò A., Palma E., Nisticò G. Intracerebral injection of human immunodeficiency virus type 1 coat glycoprotein GP120 does not produce neurodegeneration in rats. Neurosci Lett. 1994 Jul 18;176(1):97–100. doi: 10.1016/0304-3940(94)90880-x. [DOI] [PubMed] [Google Scholar]
  5. Clark R. F., Goate A. M. Molecular genetics of Alzheimer's disease. Arch Neurol. 1993 Nov;50(11):1164–1172. doi: 10.1001/archneur.1993.00540110044004. [DOI] [PubMed] [Google Scholar]
  6. Forss-Petter S., Danielson P. E., Catsicas S., Battenberg E., Price J., Nerenberg M., Sutcliffe J. G. Transgenic mice expressing beta-galactosidase in mature neurons under neuron-specific enolase promoter control. Neuron. 1990 Aug;5(2):187–197. doi: 10.1016/0896-6273(90)90308-3. [DOI] [PubMed] [Google Scholar]
  7. Giulian D., Wendt E., Vaca K., Noonan C. A. The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2769–2773. doi: 10.1073/pnas.90.7.2769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Goate A., Chartier-Harlin M. C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991 Feb 21;349(6311):704–706. doi: 10.1038/349704a0. [DOI] [PubMed] [Google Scholar]
  9. Gurwitz D., Cunningham D. D. Neurite outgrowth activity of protease nexin-1 on neuroblastoma cells requires thrombin inhibition. J Cell Physiol. 1990 Jan;142(1):155–162. doi: 10.1002/jcp.1041420119. [DOI] [PubMed] [Google Scholar]
  10. Hill J. M., Mervis R. F., Avidor R., Moody T. W., Brenneman D. E. HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates. Brain Res. 1993 Feb 19;603(2):222–233. doi: 10.1016/0006-8993(93)91241-j. [DOI] [PubMed] [Google Scholar]
  11. Johnson W. B., Ruppe M. D., Rockenstein E. M., Price J., Sarthy V. P., Verderber L. C., Mucke L. Indicator expression directed by regulatory sequences of the glial fibrillary acidic protein (GFAP) gene: in vivo comparison of distinct GFAP-lacZ transgenes. Glia. 1995 Mar;13(3):174–184. doi: 10.1002/glia.440130304. [DOI] [PubMed] [Google Scholar]
  12. Lipton S. A. HIV-related neuronal injury. Potential therapeutic intervention with calcium channel antagonists and NMDA antagonists. Mol Neurobiol. 1994 Apr-Jun;8(2-3):181–196. doi: 10.1007/BF02780669. [DOI] [PubMed] [Google Scholar]
  13. Lipton S. A. Requirement for macrophages in neuronal injury induced by HIV envelope protein gp120. Neuroreport. 1992 Oct;3(10):913–915. doi: 10.1097/00001756-199210000-00023. [DOI] [PubMed] [Google Scholar]
  14. Lipton S. A., Sucher N. J., Kaiser P. K., Dreyer E. B. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron. 1991 Jul;7(1):111–118. doi: 10.1016/0896-6273(91)90079-f. [DOI] [PubMed] [Google Scholar]
  15. Löffler J., Huber G. Beta-amyloid precursor protein isoforms in various rat brain regions and during brain development. J Neurochem. 1992 Oct;59(4):1316–1324. doi: 10.1111/j.1471-4159.1992.tb08443.x. [DOI] [PubMed] [Google Scholar]
  16. MacDonald M. C., Robertson H. A., Wilkinson M. Age- and dose-related NMDA induction of Fos-like immunoreactivity and c-fos mRNA in the arcuate nucleus of immature female rats. Brain Res Dev Brain Res. 1993 Jun 8;73(2):193–198. doi: 10.1016/0165-3806(93)90138-z. [DOI] [PubMed] [Google Scholar]
  17. Masliah E., Achim C. L., Ge N., DeTeresa R., Terry R. D., Wiley C. A. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol. 1992 Sep;32(3):321–329. doi: 10.1002/ana.410320304. [DOI] [PubMed] [Google Scholar]
  18. Masliah E., Fagan A. M., Terry R. D., DeTeresa R., Mallory M., Gage F. H. Reactive synaptogenesis assessed by synaptophysin immunoreactivity is associated with GAP-43 in the dentate gyrus of the adult rat. Exp Neurol. 1991 Aug;113(2):131–142. doi: 10.1016/0014-4886(91)90169-d. [DOI] [PubMed] [Google Scholar]
  19. Masliah E., Mallory M., Ge N., Saitoh T. Amyloid precursor protein is localized in growing neurites of neonatal rat brain. Brain Res. 1992 Oct 16;593(2):323–328. doi: 10.1016/0006-8993(92)91329-d. [DOI] [PubMed] [Google Scholar]
  20. Mattson M. P., Barger S. W., Cheng B., Lieberburg I., Smith-Swintosky V. L., Rydel R. E. beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease. Trends Neurosci. 1993 Oct;16(10):409–414. doi: 10.1016/0166-2236(93)90009-b. [DOI] [PubMed] [Google Scholar]
  21. Mattson M. P., Cheng B., Culwell A. R., Esch F. S., Lieberburg I., Rydel R. E. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein. Neuron. 1993 Feb;10(2):243–254. doi: 10.1016/0896-6273(93)90315-i. [DOI] [PubMed] [Google Scholar]
  22. Mattson M. P., Tomaselli K. J., Rydel R. E. Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF. Brain Res. 1993 Sep 3;621(1):35–49. doi: 10.1016/0006-8993(93)90295-x. [DOI] [PubMed] [Google Scholar]
  23. Miyazaki K., Hasegawa M., Funahashi K., Umeda M. A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor. Nature. 1993 Apr 29;362(6423):839–841. doi: 10.1038/362839a0. [DOI] [PubMed] [Google Scholar]
  24. Monard D. Cell-derived proteases and protease inhibitors as regulators of neurite outgrowth. Trends Neurosci. 1988 Dec;11(12):541–544. doi: 10.1016/0166-2236(88)90182-8. [DOI] [PubMed] [Google Scholar]
  25. Mucke L., Masliah E., Johnson W. B., Ruppe M. D., Alford M., Rockenstein E. M., Forss-Petter S., Pietropaolo M., Mallory M., Abraham C. R. Synaptotrophic effects of human amyloid beta protein precursors in the cortex of transgenic mice. Brain Res. 1994 Dec 15;666(2):151–167. doi: 10.1016/0006-8993(94)90767-6. [DOI] [PubMed] [Google Scholar]
  26. Smith-Swintosky V. L., Pettigrew L. C., Craddock S. D., Culwell A. R., Rydel R. E., Mattson M. P. Secreted forms of beta-amyloid precursor protein protect against ischemic brain injury. J Neurochem. 1994 Aug;63(2):781–784. doi: 10.1046/j.1471-4159.1994.63020781.x. [DOI] [PubMed] [Google Scholar]
  27. Tardy M., Fages C., Riol H., LePrince G., Rataboul P., Charriere-Bertrand C., Nunez J. Developmental expression of the glial fibrillary acidic protein mRNA in the central nervous system and in cultured astrocytes. J Neurochem. 1989 Jan;52(1):162–167. doi: 10.1111/j.1471-4159.1989.tb10911.x. [DOI] [PubMed] [Google Scholar]
  28. Toggas S. M., Masliah E., Rockenstein E. M., Rall G. F., Abraham C. R., Mucke L. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature. 1994 Jan 13;367(6459):188–193. doi: 10.1038/367188a0. [DOI] [PubMed] [Google Scholar]
  29. Wiley C. A., Masliah E., Morey M., Lemere C., DeTeresa R., Grafe M., Hansen L., Terry R. Neocortical damage during HIV infection. Ann Neurol. 1991 Jun;29(6):651–657. doi: 10.1002/ana.410290613. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES